The company intends to use the funds to accelerate the buildout of its automated AI Science Factories, expand its multi-agent software platform, scale its material and chemical simulation infrastructure, and grow its international engineering team.

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

Undisclosed
Cambridge, MA Undisclosed
USA

Phone

Undisclosed

Website

www.lila.ai

Email Address

Not Recorded

Overview

Our mission is to build scientific superintelligence to solve humankind's greatest challenges. New science begins where existing knowledge ends. New medicines and materials are forged beyond the edge of what is known. We predict, we test, we learn, we create. With each idea and experiment, we turn the wheel of science.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Geoffrey von Maltzahn

Browse more venture capital transactions:

Prev: 6/4/2026: CereVasc venture capital transaction
Next: 6/4/2026: Offroad venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to report on every notable VC transaction. VC transactions reported here are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary